Friday, February 1, 2013

The pancreas cancer gene is diagnosed to obtain _ symptom of the break-through

The pancreas cancer gene is diagnosed to obtain _ symptom of the break-through
The second medical university doctoral candidate in Shanghai presents the brilliance of the rising sun of allusion quatation with respect to find in a research recently, it is expressed that blood plasma K-ras mutation, and CCK-A receptor are peculiar in pancreas cancer is organized, diagnose the index of the pancreas with quite valuable cancer. This research results, in order to diagnose pancreas cancer has opened up the new route in early days. It is introduced in recent years, pancreas the intersection of cancer and morbidity rise constantly, mortality high, main reason its cancer very much difficult to act as early diagnosis like other malignant tumour because of pancreas. At present, the gene mutation measuring the pancreas and organizing, often need the operation to obtain the sample, or adopt the thin needle to puncture and obtain the sample, this diagnoses to the skill it is the obstacle that one is very great in early days. Whether could measure the cancer gene or restrain the mutation of the cancer gene, diagnose the break-through point studied from the blood in early days as pancreas cancer. Under a professor's guidance of famous surgical expert of the hospital of Shanghai Rui Jin Lin YanZhen, Zhang Sheng, presenting the brilliance of the rising sun of allusion quatation with respect sets up the method measured in blood plasma K-ras, P53 gene mutation at first under study for action, and canvass its clinical meaning in pancreas cancer patient blood plasma. Then, he combines the serum tumour mark again, appraises blood plasma K-ras gene mutation and measures the diagnosis value to pancreas cancer prospectively, expression research of CCK-A receptor gene while organizing pancreas cancer finally, and obtained the gratifying conclusion, this achievement contributes to using the genetic means to diagnose pancreas cancer early.
|

0 comments:

Post a Comment